{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T13:45:26Z","timestamp":1767966326058,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,31]],"date-time":"2024-03-31T00:00:00Z","timestamp":1711843200000},"content-version":"am","delay-in-days":304,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["81XWH-17-1-0532"],"award-info":[{"award-number":["81XWH-17-1-0532"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.ahj.2023.02.002","type":"journal-article","created":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T21:56:53Z","timestamp":1677103013000},"page":"100-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["The teammate trial: Study design and rationale tacrolimus and everolimus against tacrolimus and MMF in pediatric heart transplantation using the major adverse transplant event (MATE) score"],"prefix":"10.1016","volume":"260","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7136-8337","authenticated-orcid":false,"given":"Christopher S.","family":"Almond","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn A.","family":"Sleeper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph W.","family":"Rossano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"Bock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elfriede","family":"Pahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Auerbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashwin","family":"Lal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seth A.","family":"Hollander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelley D.","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chesney","family":"Castleberry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynsey M.","family":"Barkoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selena","family":"Gonzales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin P.","family":"Daly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2023.02.002_bib0001","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.healun.2018.07.018","article-title":"The international thoracic organ transplant registry of the international society for heart and lung transplantation: twenty-first pediatric heart transplantation report-2018; focus theme: multiorgan transplantation","volume":"37","author":"Rossano","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ahj.2023.02.002_bib0002","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.healun.2017.03.013","article-title":"Development and validation of a major adverse transplant event (MATE) score to predict late graft loss in pediatric heart transplantation","volume":"37","author":"Almond","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ahj.2023.02.002_bib0003","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1399-3046.2011.01564.x","article-title":"Risk factors for late renal dysfunction after pediatric heart transplantation: a multi-institutional study","volume":"15","author":"Feingold","year":"2011","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.ahj.2023.02.002_bib0004","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.healun.2022.02.018","article-title":"The evolution of pediatric heart retransplantation over three decades: An analysis from the PHTS","volume":"41","author":"Vazquez Alvarez","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ahj.2023.02.002_bib0005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.critrevonc.2005.03.012","article-title":"Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacy","volume":"56","author":"Taylor","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ahj.2023.02.002_bib0006","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/ajt.12181","article-title":"Everolimus versus mycophenolate mofetil in heart transplantation: a randomized, multicenter trial","volume":"13","author":"Eisen","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ahj.2023.02.002_bib0007","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.healun.2016.09.009","article-title":"Use of sirolimus in pediatric heart transplant patients: A multi-institutional study from the Pediatric Heart Transplant Study Group","volume":"36","author":"Rossano","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ahj.2023.02.002_bib0008","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/ajt.13588","article-title":"Everolimus initiation with early calcineurin inhibitor withdrawal in de novo heart transplant recipients: three-year results from the randomized SCHEDULE Study","volume":"16","author":"Andreassen","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ahj.2023.02.002_bib0009","first-page":"1","article-title":"Conversion from calcineurin inhibitors to mTOR inhibitors as primary immunosuppressive drugs in pediatric heart transplantation","author":"Asante-Korang","year":"2017","journal-title":"Clin Transplant"},{"key":"10.1016\/j.ahj.2023.02.002_bib0010","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJMoa022171","article-title":"Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients","volume":"349","author":"Eisen","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2023.02.002_bib0011","doi-asserted-by":"crossref","first-page":"S406","DOI":"10.1016\/j.healun.2016.01.1174","article-title":"Calcineurin-inhibitor minimization in pediatric heart transplant recipients","volume":"35","author":"Bock","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ahj.2023.02.002_bib0012","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1016\/j.healun.2017.01.274","article-title":"Safety problems associated with extemporaneously-prepared liquid tacrolimus in us children after heart transplantation","volume":"36","author":"McDonald","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ahj.2023.02.002_bib0013","unstructured":"Zortress (Everolimus) Package Insert. Novartis Interenational, Inc. https:\/\/www.novartis.us\/sites\/www.novartis.us\/files\/zortress.pdf [accessed 23 May, 2022]"},{"key":"10.1016\/j.ahj.2023.02.002_bib0014","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1399-3046.2011.01566.x","article-title":"Calcineurin inhibitor minimization using sirolimus leads to improved renal function in pediatric heart transplant recipients","volume":"15","author":"Chinnock","year":"2011","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.ahj.2023.02.002_bib0015","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1399-3046.2010.01306.x","article-title":"Indications, tolerance and complications of a sirolimus and calcineurin inhibitor immunosuppression regimen: intermediate experience in pediatric heart transplantation recipients","volume":"14","author":"Matthews","year":"2010","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.ahj.2023.02.002_bib0016","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/CIRCULATIONAHA.109.927988","article-title":"Enalapril in infants with single ventricle: results of a multicenter randomized trial","volume":"122","author":"Hsu","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.02.002_bib0017","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1056\/NEJMoa1404731","article-title":"Atenolol versus losartan in children and young adults with Marfan's syndrome","volume":"371","author":"Lacro","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2023.02.002_bib0018","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1056\/NEJMoa0912461","article-title":"Comparison of shunt types in the Norwood procedure for single-ventricle lesions","volume":"362","author":"Ohye","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2023.02.002_bib0019","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1001\/jama.298.10.1171","article-title":"Carvedilol for children and adolescents with heart failure: a randomized controlled trial","volume":"298","author":"Shaddy","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2023.02.002_bib0020","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0003-4975(10)66846-4","article-title":"Effect of crossover on the statistical power of randomized studies","volume":"48","author":"Weinstein","year":"1989","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ahj.2023.02.002_bib0021","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/sim.4780080407","article-title":"Surrogate endpoints in clinical trials: definition and operational criteria","volume":"8","author":"Prentice","year":"1989","journal-title":"Stat Med"},{"key":"10.1016\/j.ahj.2023.02.002_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/petr.13013","article-title":"Clinical practice patterns are relatively uniform between pediatric heart transplant centers: A survey-based assessment","volume":"21","author":"Castleberry","year":"2017","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.ahj.2023.02.002_bib0023","doi-asserted-by":"crossref","first-page":"e14124","DOI":"10.1111\/petr.14124","article-title":"Early findings after integration of donor-derived cell-free DNA into clinical care following pediatric heart transplantation","volume":"26","author":"Feingold","year":"2022","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.ahj.2023.02.002_bib0024","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.healun.2019.11.015","article-title":"Donor fraction cell-free DNA and rejection in adult and pediatric heart transplantation","volume":"39","author":"Richmond","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ahj.2023.02.002_bib0025","unstructured":"TEAMMATE Trial Public Website. Liquid preparation of tacrolimus instructional video. 2016. https:\/\/med.stanford.edu\/teammate.html. [accessed 23 May, 2022]"},{"key":"10.1016\/j.ahj.2023.02.002_bib0026","unstructured":"TEAMMATE Trial Public Website. Informed Consent Video. https:\/\/med.stanford.edu\/teammate.html [accessed May 23, 2022]"},{"key":"10.1016\/j.ahj.2023.02.002_bib0027","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1542\/peds.111.6.1416","article-title":"National kidney foundation's kidney disease outcomes quality initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification","volume":"111","author":"Hogg","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.ahj.2023.02.002_bib0028","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.healun.2010.05.017","article-title":"International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010","volume":"29","author":"Mehra","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ahj.2023.02.002_bib0029","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jacc.2015.05.063","article-title":"Improved detection of cardiac allograft vasculopathy: a multi-institutional analysis of functional parameters in pediatric heart transplant recipients","volume":"66","author":"Kindel","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.02.002_bib0030","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.healun.2005.03.019","article-title":"Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection","volume":"24","author":"Stewart","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ahj.2023.02.002_bib0031","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.healun.2013.08.011","article-title":"The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation","volume":"32","author":"Berry","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ahj.2023.02.002_bib0032","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.healun.2011.01.701","article-title":"A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients","volume":"30","author":"Husain","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ahj.2023.02.002_bib0033","series-title":"WHOClassification of tumours of haematopoietic and lymphoid tissues.Post-transplant lymphoproliferative disorders","author":"Swerdlow","year":"2008"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870323000388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870323000388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T09:59:29Z","timestamp":1762077569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870323000388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":33,"alternative-id":["S0002870323000388"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2023.02.002","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The teammate trial: Study design and rationale tacrolimus and everolimus against tacrolimus and MMF in pediatric heart transplantation using the major adverse transplant event (MATE) score","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2023.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}